An FDA advisory committee is meeting today to review MDMA-assisted psychotherapy to treat PTSD. Follow STAT's live blog throughout the day for updates.
  • jeffw@lemmy.worldOPEnglish
    6·
    6 months ago

    Yeah, it’s not shocking that the FDA didn’t like it, although the research is promising